One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2018-99-112847
Copy DOI Journal: Blood |  Publication Date: Nov 29, 2018 |
Affiliation: Seagen (United States), Quest Diagnostics (United States), Johannes Wesling Klinikum Minden, The Maria Sklodowska-Curie National Research Institute of Oncology, Millennium Engineering and Integration (United States), Takeda (United States), University Hospital Schleswig-Holstein, University of Lübeck, University of Virginia, NIHR Surgical Reconstruction and Microbiology Research Centre, KU Leuven, University of California, Los Angeles, University of Turin, Peter MacCallum Cancer Centre, University of Melbourne, Istituto di Ematologia di Bologna, Guy's and St Thomas' NHS Foundation Trust, University Hospital of Zurich, University of Pittsburgh, The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, University of California, Irvine, Universidade de São Paulo, Dana-Farber Cancer Institute, Research Institute Hospital 12 de Octubre, Concord Repatriation General Hospital, University of SydneySuperior Clinical Benefit of Brentuximab Vedotin in Mycosis Fungoides Versus Physician's Choice Irrespective of CD30 Level or Large Cell Transformation Status in the Phase 3 ALCANZA Study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
